Sinubide 50 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
MFDS item code 202100092 · Approved 2021.01.06
This product's status changed to Expired on 2026.01.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to improve blood glucose control in patients with type 2 diabetes. It can be administered alone as an initial treatment, and for patients who have not previously taken antidiabetic medications and find blood glucose control challenging with monotherapy, it can be combined with metformin. Additionally, if blood glucose control is insufficient with monotherapy using sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be taken together to enhance therapeutic effect. Furthermore, if adequate blood glucose control is not achieved even with multiple medications, this medication can be used additionally. Thus, this medication effectively aids in blood glucose management across various treatment stages, improving blood glucose control.
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment based on renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.
This medication may rarely cause severe allergic reactions; thus, if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and seek medical attention. Pancreatitis may occur during medication use, so if symptoms such as sudden abdominal pain, vomiting, or nausea appear, visit a hospital immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, nor should those with allergies to this medication or its components. Patients with impaired kidney function need to adjust the dosage, therefore regular kidney function tests and adherence to doctor's instructions are necessary. During medication use, symptoms similar to a cold, headaches, dyspepsia, diarrhea, etc., may occur, and symptoms of hypoglycemia may also appear, making it important to monitor blood glucose frequently. Especially when taken together with other hypoglycemic agents like insulin or sulfonylureas, the risk of hypoglycemia is increased, so dosage adjustments should be discussed with a doctor if these medications are in use. If severe joint pain or skin blistering appears, inform a doctor immediately, and if necessary, discontinue medication. Use during pregnancy or breastfeeding is not recommended, so consult with a doctor before taking. Elderly patients may experience reduced kidney function; thus, kidney function should be periodically checked before and during medication use, and dosage adjustments may be needed. In the case of overdose, visit a hospital immediately for appropriate treatment since this medication can be partially removed by hemodialysis, which may be helpful if necessary. Co-administration with other medications has a low potential for drug interactions; however, caution is needed when taken with cyclosporine or digoxin due to possible changes in blood concentration.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage conditions will help maintain the medication's effectiveness.
Light yellow pink round biconvex film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.